Continuous glucose monitoring goes mainstream
Continuous glucose monitoring is expanding beyond type 1 diabetes into type 2 management and even non-diabetic wellness use.
Continuous glucose monitoring is no longer a type-1-only device category. Type 2 diabetes coverage has broadened, and non-diabetic wellness use - whatever its clinical merit - is now a real consumer market. Each of those streams pulls the category in a different direction.
Continue reading
Full intelligence on PanaceaIntel
PatientSpotlight publishes the headline framing. The full brief, the editorial takeaway, and the source list sit on PanaceaIntel for entitled clients.
New to PanaceaIntel? Request access and the team will reply within one working day.
Related
- SnapshotHFrEF therapy reference (2026)
- SnapshotType 1 diabetes therapy reference (2026)
- ExplainedWhat is heart failure?
← Back to Signals
Published by PatientSpotlight, by PanaceaIntel.